Julie Hambleton Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Julie Hambleton.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Julie Hambleton. Julie Hambleton is EVP & Chief Medical Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and SVP & Chief Medical Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in IGM Biosciences, Inc. ($IGMS) and SVP, Chief Medical Officer in IDEAYA Biosciences, Inc. ($IDYA) and Director in SpringWorks Therapeutics, Inc. ($SWTX).
Latest Insider Trading Transactions of Julie Hambleton
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FPRX, IDYA, IGMS, SWTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2021 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Sell | S | 80.00 | 2,000 | 160,000 | 3,000 | 5 K to 3 K (-40.00 %) |
| Jun 03 2021 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Sell | S | 80.00 | 2,000 | 160,000 | 3,000 | 5 K to 3 K (-40.00 %) |
| May 21 2021 | SWTX | SpringWorks Therap ... | Hambleton Julie | Director | Option Exercise | A | 75.94 | 6,998 | 531,428 | 6,998 | |
| May 21 2021 | SWTX | SpringWorks Therap ... | Hambleton Julie | Director | Grant | A | 0.00 | 1,106 | 0 | 5,995 | 4.9 K to 6 K (+22.62 %) |
| Feb 23 2021 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Option Exercise | A | 91.50 | 6,423 | 587,705 | 6,423 | |
| Feb 25 2020 | IDYA | IDEAYA Biosciences ... | Hambleton Julie | SVP, Chief Medical ... | Option Exercise | A | 6.92 | 62,500 | 432,500 | 62,500 | |
| Feb 07 2020 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Option Exercise | A | 40.27 | 10,000 | 402,700 | 10,000 | |
| Sep 20 2019 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Buy | P | 18.31 | 5,000 | 91,550 | 5,000 | 0 to 5 K |
| Sep 20 2019 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Buy | P | 18.31 | 5,000 | 91,550 | 5,000 | 0 to 5 K |
| Sep 19 2019 | IGMS | IGM Biosciences, I ... | Hambleton Julie | Director | Option Exercise | A | 16.00 | 12,100 | 193,600 | 12,100 | |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Option Exercise | M | 11.14 | 12,000 | 133,680 | 38,000 | |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Option Exercise | M | 7.26 | 10,000 | 72,600 | 14,390 | |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Sell | S | 35.33 | 1,108 | 39,146 | 84,811 | 85.9 K to 84.8 K (-1.29 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Sell | S | 34.33 | 12,000 | 411,960 | 85,919 | 97.9 K to 85.9 K (-12.26 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | M | 11.14 | 12,000 | 133,680 | 97,919 | 85.9 K to 97.9 K (+13.97 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Sell | S | 35.23 | 3,400 | 119,782 | 85,919 | 89.3 K to 85.9 K (-3.81 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Sell | S | 34.75 | 6,600 | 229,350 | 89,319 | 95.9 K to 89.3 K (-6.88 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | M | 7.26 | 10,000 | 72,600 | 95,919 | 85.9 K to 95.9 K (+11.64 %) |
| Oct 30 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | P | 13.70 | 64 | 877 | 64 | 0 to 64 |
| Oct 30 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | P | 10.75 | 400 | 4,300 | 1,700 | 1.3 K to 1.7 K (+30.77 %) |
| Oct 30 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | P | 10.10 | 500 | 5,050 | 1,300 | 800 to 1.3 K (+62.50 %) |
| Oct 30 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | P | 14.75 | 800 | 11,800 | 800 | 0 to 800 |
| Aug 21 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Grant | A | 0.00 | 75,000 | 0 | 85,740 | 10.7 K to 85.7 K (+698.32 %) |
| Aug 19 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | SVP & Chief Medical ... | Option Exercise | A | 19.25 | 75,000 | 1,443,750 | 75,000 | |
| May 04 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | SVP & Chief Medical ... | Grant | A | 0.00 | 7,980 | 0 | 9,979 | 2 K to 10 K (+399.20 %) |
| Aug 26 2014 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | SVP & Chief Medical ... | Option Exercise | A | 11.14 | 50,000 | 557,000 | 50,000 |
Page: 1